Joanina K Gicobi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Drug Administration

Renal Cell Carcinoma

Editorial Comment

Top Venues

Science advances

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Joanina K Gicobi, Zhiming Mao, Grace DeFranco, Jacob B Hirdler, Ying Li, Vianca V Vianzon, Emilia R Dellacecca, Michelle A Hsu, Whitney Barham, Yiyi Yan, Aaron S Mansfield, Yi Lin, Xiaosheng Wu, Taro Hitosugi, Dawn Owen, Michael P Grams, Jacob J Orme, Fabrice Lucien, Hu Zeng, Sean S Park, Haidong Dong
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8 + T cells via ME1 up-regulation. Science advances 9 (46) (2023)
Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Zesheng An, Michelle A Hsu, Joanina K Gicobi, Tianxiao Xu, Susan M Harrington, Henan Zhang, Kevin D Pavelko, Jacob B Hirdler, Christine M Lohse, Reza Nabavizadeh, Rodrigo R Pessoa, Vidit Sharma, R Houston Thompson, Bradley C Leibovich, Haidong Dong, Fabrice Lucien
A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. Journal of immunology (Baltimore, Md. : 1950) (2023)